Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

A Dormant Microbial Component in the Development of Preeclampsia.

Kell DB, Kenny LC.

Front Med (Lausanne). 2016 Nov 29;3:60. eCollection 2016. Review.

2.

Systematic review of statins in sepsis: There is no evidence of dose response.

Quinn M, Moody C, Tunnicliffe B, Khan Z, Manji M, Gudibande S, Murphy N, Whitehouse T, Snelson C, Veenith T.

Indian J Crit Care Med. 2016 Sep;20(9):534-41. doi: 10.4103/0972-5229.190366.

3.

Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

National Heart, Lung, and Blood Institute ARDS Clinical Trials Network., Truwit JD, Bernard GR, Steingrub J, Matthay MA, Liu KD, Albertson TE, Brower RG, Shanholtz C, Rock P, Douglas IS, deBoisblanc BP, Hough CL, Hite RD, Thompson BT.

N Engl J Med. 2014 Jun 5;370(23):2191-200. doi: 10.1056/NEJMoa1401520. Epub 2014 May 18.

4.

Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: an experimental study.

Araz O, Demirci E, Yilmazel Ucar E, Calik M, Pulur D, Karaman A, Yayla M, Altun E, Halici Z, Akgun M.

Multidiscip Respir Med. 2013 Dec 17;8(1):74. doi: 10.1186/2049-6958-8-74.

5.

Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial).

Patel JM, Snaith C, Thickett DR, Linhartova L, Melody T, Hawkey P, Barnett AH, Jones A, Hong T, Cooke MW, Perkins GD, Gao F.

Crit Care. 2012 Dec 11;16(6):R231. doi: 10.1186/cc11895.

6.

Predictors of hospital-acquired urinary tract-related bloodstream infection.

Greene MT, Chang R, Kuhn L, Rogers MA, Chenoweth CE, Shuman E, Saint S.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1001-7. doi: 10.1086/667731. Epub 2012 Aug 23.

7.

Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis.

Calisto KL, Camacho AC, Mittestainer FC, Carvalho BM, Guadagnini D, Carvalheira JB, Saad MJ.

Crit Care. 2012 Aug 16;16(4):R158. doi: 10.1186/cc11478. Retraction in: Calisto KL, Camacho AC, Mittestainer FC, Carvalho BM, Guadagnini D, Carvalheira JB, Saad MJ. Crit Care. 2016;20:278.

8.

Risk factors for acute organ failure in intensive care unit patients who receive respiratory support in the absence of non-respiratory organ failure: an international prospective cohort study.

Terblanche M, Kruger P, di Gangi S, Gearay S, Gilfeather L, Ferguson ND, Pearse R, Beale R, Rhodes A, Brett SJ, McAuley DF.

Crit Care. 2012 Dec 12;16(2):R61. doi: 10.1186/cc11306.

9.

Statin therapy as prevention against development of acute respiratory distress syndrome: an observational study.

Bajwa EK, Malhotra CK, Thompson BT, Christiani DC, Gong MN.

Crit Care Med. 2012 May;40(5):1470-7. doi: 10.1097/CCM.0b013e3182416d7a.

10.

Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study.

Cadirci E, Halici Z, Odabasoglu F, Albayrak A, Karakus E, Unal D, Atalay F, Ferah I, Unal B.

Clin Exp Immunol. 2011 Dec;166(3):374-84. doi: 10.1111/j.1365-2249.2011.04483.x.

11.

Statins: a role in infected critically ill patients?

Truwit JD.

Crit Care. 2011;15(2):145. doi: 10.1186/cc10086. Epub 2011 Apr 1.

12.

Effect of statin treatment on short term mortality after pneumonia episode: cohort study.

Douglas I, Evans S, Smeeth L.

BMJ. 2011 Apr 6;342:d1642. doi: 10.1136/bmj.d1642.

13.

Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study.

Terblanche MJ, Pinto R, Whiteley C, Brett S, Beale R, Adhikari NK.

Crit Care. 2011;15(1):R74. doi: 10.1186/cc10063. Epub 2011 Feb 28.

14.

Atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling.

Calisto KL, Carvalho Bde M, Ropelle ER, Mittestainer FC, Camacho AC, Guadagnini D, Carvalheira JB, Saad MJ.

PLoS One. 2010 Dec 6;5(12):e14232. doi: 10.1371/journal.pone.0014232. Erratum in: PLoS One. 2015;10(3):e0118383. Retraction in: Calisto KL, Carvalho Bde M, Ropelle ER, Mittestainer FC, Camacho AC, Guadagnini D, Carvalheira JB, Saad MJ. PLoS One. 2016;11(7):e0159283.

15.

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Parquet V, Henry M, Wurtz N, Dormoi J, Briolant S, Gil M, Baret E, Amalvict R, Rogier C, Pradines B.

Malar J. 2010 May 25;9:139. doi: 10.1186/1475-2875-9-139.

16.

Statin research in critical illness: hampered by poor trial design?

Terblanche M, Adhikari NK.

Crit Care. 2009;13(6):1015. doi: 10.1186/cc8173. Epub 2009 Dec 11.

17.

Synergistic antibacterial and anti-inflammatory activity of temporin A and modified temporin B in vivo.

Capparelli R, Romanelli A, Iannaccone M, Nocerino N, Ripa R, Pensato S, Pedone C, Iannelli D.

PLoS One. 2009 Sep 28;4(9):e7191. doi: 10.1371/journal.pone.0007191.

18.

Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study.

Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, Cheng AC, Celermajer DS, Stephens DP, Anstey NM.

Crit Care. 2009;13(5):R155. doi: 10.1186/cc8055. Epub 2009 Sep 25.

19.

Preinjury statin use is associated with a higher risk of multiple organ failure after injury: a propensity score adjusted analysis.

Neal MD, Cushieri J, Rosengart MR, Alarcon LH, Moore EE, Maier RV, Minei JP, Billiar TR, Peitzman AB, Sperry JL; Inflammation and Host Response to Injury Investigators..

J Trauma. 2009 Sep;67(3):476-82; discussion 482-4. doi: 10.1097/TA.0b013e3181ad66bb.

20.

Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.

Parquet V, Briolant S, Torrentino-Madamet M, Henry M, Almeras L, Amalvict R, Baret E, Fusaï T, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2009 Jun;53(6):2248-52. doi: 10.1128/AAC.01462-08. Epub 2009 Mar 23.

Supplemental Content

Support Center